Mobileye (MBLY) Q1 2026 earnings review
A Volume Surge Masking Underlying Margin and Growth Issues
Mobileye delivered a massive Q1 revenue beat (+27% YoY) driven by a 28% surge in EyeQ volumes as customers replenished depleted safety stocks. However, the headlines are dominated by a massive $3.79 billion non-cash goodwill impairment, acknowledging a severe decline in market capitalization and geopolitical realities. Even excluding the impairment, the quality of earnings is mixed: adjusted gross margins compressed by 241 basis points due to a shifting product mix, and ASPs declined. Most concerning is the guidance: despite raising the full-year outlook, backing out Q1's outperformance reveals that management expects revenue to contract over the next three quarters. The $591 million Mentee Robotics acquisition has now closed, draining cash and adding execution risk just as core ADAS pricing power softens.
🐂 Bull Case
The 28% YoY surge in EyeQ SoC volumes proves that the painful inventory corrections of 2024 and late 2025 are finished. Demand is normalizing at a healthy rate.
Adjusted operating margins expanded from 13% to 17% YoY. Revenue grew 27%, but adjusted operating income grew 61%, showing Mobileye can tightly control OpEx even as volumes scale.
🐻 Bear Case
Full-year revenue guidance midpoint is $1.975B. Subtracting Q1's $558M leaves $1.417B for the rest of the year—a roughly 3% YoY decline compared to the same period in 2025.
Adjusted Gross Margin fell from 69% to 66% as Average System Price (ASP) dropped sequentially to $49.30, indicating a less profitable product mix.
⚖️ Verdict: 🔴
Bearish. The 27% revenue growth looks fantastic in a vacuum, but it is purely a restocking anomaly. Shrinking gross margins, falling ASPs, a $3.8B impairment reality check, and a mathematically implied revenue contraction for the remainder of the year make this a low-quality beat.
Key Themes
EyeQ Volumes Reversing Upward
Reversing the dip seen in 25Q4, system shipments skyrocketed to 10.8 million units (up 28% YoY). Management explicitly credited this to the normalization of safety stock levels at Tier 1 customers after a drawdown at the end of 2025. This volume scale drove the top-line beat.
Adjusted Gross Margin Compression
Decelerating. Despite the massive volume leverage, Adjusted Gross Margin dropped 241 basis points YoY to 66%. Management blamed a higher EyeQ-related cost per unit due to product mix. Concurrently, Average System Price (ASP) dropped from $50.80 in 25Q4 to $49.30 in 26Q1, showing that volume gains are coming at the expense of unit profitability.
The $3.8 Billion Reality Check
The company recorded a massive $3.788 billion non-cash goodwill impairment charge. While non-cash, it was triggered by a sustained decline in market capitalization and increased macro/geopolitical uncertainty. This is a formal acknowledgment that the premium Intel paid for Mobileye in 2017—and the subsequent IPO valuation—has been fundamentally eroded by current market realities.
Advanced Product Portfolio Execution
Mobileye secured a new Surround ADAS and SuperVision design win with Mahindra, unlocking the growing Indian market. Furthermore, the VW/MOIA robotaxi ecosystem kicked off pre-series production in Hanover. There are now over 100 ID.Buzz AVs testing on public roads across six global cities, keeping the 2026/2027 commercialization timeline intact.
The Physical AI Pivot Drains Cash
The Mentee Robotics acquisition closed in early February, shifting Mobileye beyond automotive into humanoid robots. However, this strategic bet drained $591 million in cash. With core automotive facing macro headwinds, the market will scrutinize how much R&D budget this new 'Physical AI' segment will consume.
Other KPIs
Decelerating severely. Cash balances plummeted from $1.836B at the end of FY25 to $1.21B, primarily due to the $591M outlay for Mentee Robotics. Operating cash flow of $75M was insufficient to buffer this outflow.
The Board authorized a $250M buyback specifically to offset dilution from stock-based compensation and shares issued for the Mentee Robotics acquisition. Given the recent drop in total cash, this signals management's attempt to stabilize the share price without severely impacting liquidity.
Guidance
Decelerating. Management raised the midpoint by 2% to $1.975B. However, because Q1 generated $558M, the implied revenue for the remaining three quarters is roughly $1.417B. Compared to the $1.456B generated in Q2-Q4 of FY25, this mathematically implies a ~3% YoY revenue decline for the remainder of the year.
Accelerating vs prior guide. The midpoint was raised by 8% to $210M, reflecting strong operating leverage and tight OpEx control observed in Q1. However, this still represents a significant YoY drop compared to the $280M achieved in FY25.
A newly provided metric following the Mentee close, heavily skewed by the $3.788B goodwill impairment charge recorded in Q1, alongside high amortization and stock-based compensation expenses.
Key Questions
Implied Growth Deceleration
Your FY26 guidance implies that revenue for the remainder of the year will decline roughly 3% year-over-year. Is this purely conservatism related to macro/tariff risks, or are you seeing actual softness in OEM production schedules?
Gross Margin Compression
Adjusted gross margins fell 241 basis points YoY despite a massive volume surge. How much of this is driven by pricing pressure in China versus an unfavorable mix of lower-tier EyeQ chips, and where do you see this bottoming out?
Mentee Robotics Cash Burn
With the Mentee acquisition closing and draining nearly $600M in cash, how should we model the ongoing R&D and operational cash burn for this new Physical AI segment over the next 12-24 months?